Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$87.49

-1.13 (-1.28%)

13:00
12/13/18
12/13
13:00
12/13/18
13:00
Hot Stocks
AbbVie announces $5B boost to stock repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

, ABBV

AbbVie

$88.62

0.45 (0.51%)

08:14
12/13/18
12/13
08:14
12/13/18
08:14
Upgrade
Galapagos NV, AbbVie rating change  »

Galapagos NV upgraded to…

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

ABBV

AbbVie

$88.62

0.45 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

08:02
12/13/18
12/13
08:02
12/13/18
08:02
Recommendations
Neurocrine analyst commentary at Baird »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

07:46
12/13/18
12/13
07:46
12/13/18
07:46
Recommendations
Neurocrine analyst commentary at Leerink »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

07:39
12/13/18
12/13
07:39
12/13/18
07:39
Recommendations
Neurocrine analyst commentary at Oppenheimer »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

07:37
12/13/18
12/13
07:37
12/13/18
07:37
Recommendations
Neurocrine analyst commentary at Canaccord »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

07:09
12/13/18
12/13
07:09
12/13/18
07:09
Recommendations
Neurocrine analyst commentary at H.C. Wainwright »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

06:23
12/13/18
12/13
06:23
12/13/18
06:23
Initiation
Neurocrine initiated at Goldman Sachs »

Goldman starts Neurocrine…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

05:08
12/13/18
12/13
05:08
12/13/18
05:08
Initiation
Neurocrine initiated at Goldman Sachs »

Neurocrine initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Wednesday
LOW

Lowe's

$92.13

2.64 (2.95%)

, UA

Under Armour

$19.00

-1.87 (-8.96%)

16:23
12/12/18
12/12
16:23
12/12/18
16:23
On The Fly
Fly Intel: Wall Street's top stories for Wednesday »

Stocks were higher from…

LOW

Lowe's

$92.13

2.64 (2.95%)

UA

Under Armour

$19.00

-1.87 (-8.96%)

UAA

Under Armour

$19.81

-2.33 (-10.52%)

DB

Deutsche Bank

$9.03

0.69 (8.27%)

CRZBY

Commerzbank

$0.00

(0.00%)

TME

Tencent Music

$14.11

(0.00%)

BHC

Bausch Health

$24.12

1.03 (4.46%)

SGYP

Synergy Pharmaceuticals

$0.16

-0.18 (-52.94%)

URI

United Rentals

$108.27

6.38 (6.26%)

NBIX

Neurocrine

$73.83

-11.89 (-13.87%)

PLAY

Dave & Buster's

$47.03

-4.05 (-7.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 14

    Dec

  • 15

    Feb

  • 25

    Feb

  • 27

    Feb

  • 03

    Mar

  • 12

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.